Abbott
As on 21 Feb, 2026 | 02:29 IST
| Open | 112.19 |
| Previous Close | 112.19 |
| Beta | 0.13 |
| High | 112.64 |
| Low | 111.18 |
| TTM EPS See historical trend | 5.15(+10.28% YoY) |
| 52 Week High | 141.07 |
| 52 Week Low | 105.28 |
| TTM PE See historical trend | 21.79(High PE) |
| Mkt. Cap ($ Billion) | 194.64 |
| Dividend Yield | 1.92 |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 112.52 |
| 10 | 112.18 |
| 20 | 110.17 |
| 50 | 118.56 |
| 100 | 123.65 |
| 200 | 127.88 |
Returns
| 1 Week | -0.35% | |
| 1 Month | -7.36% | |
| 3 Months | -9.48% | |
| YTD | -10.42% | |
| 1 Year | -15.76% | |
| 3 Years | 5.13% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| J&J | 242.29 | -1.87 | 584.37 | 22.45 | 10.80 | 2.50 | 246.87/143.68 | 11.18 | Very Bullish |
| Thermo Fisher Scientific | 510.93 | -0.81 | 194.84 | 22.34 | 22.87 | 0.30 | 643.99/385.72 | -17.44 | Bearish |
| Abbott | 112.21 | 0.02 | 194.64 | 21.79 | 5.15 | 1.92 | 141.07/105.28 | -7.36 | Bearish |
| Intuitive Surgical | 503.74 | 0.84 | 178.56 | 56.41 | 8.93 | -- | 605.98/427.84 | -4.44 | Neutral |
| Danaher | 209.66 | -0.75 | 151.36 | 26.87 | 7.80 | 0.56 | 242.75/171.26 | -10.36 | Very Bearish |
Market news
- S&P 500 ends up slightly as tech dips, inflation coolsFebruary 14, 2026 9:22 AM
- Dow Jones Industrial Average breaks 50,000 level for first timeFebruary 7, 2026 9:16 AM
- US stocks fall, as investors fret over Trump's Fed nominee, earnings, inflationJanuary 31, 2026 8:34 AM
- Dow ends lower after topsy-turvy week, as Intel's outlook weighs on market sentimentJanuary 24, 2026 8:43 AM
About the company
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.